LifeStance Health Group Inc (LFST) Analysis & Forecast for 2024

LifeStance Health Group Inc (NASDAQ: LFST) is -10.73% lower on its value in year-to-date trading and has touched a low of $4.63 and a high of $9.59 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LFST stock was last observed hovering at around $6.64 in the last trading session, with the day’s gains setting it 0.35%.

Currently trading at $6.99, the stock is 8.64% and 1.19% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.43 million and changing 5.27% at the moment leaves the stock -6.53% off its SMA200. LFST registered 37.60% gain for a year compared to 6-month loss of -14.34%. The firm has a 50-day simple moving average (SMA 50) of $3.08 and a 200-day simple moving average (SMA200) of -$24.91.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a -0.71% gain in the last 1 month and extending the period to 3 months gives it a 24.38%, and is 22.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.15% over the week and 6.61% over the month.

Profit margin for the company is -18.71%. Distance from 52-week low is 50.97% and -27.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-9.92%).

LifeStance Health Group Inc quarterly earnings per share for the current quarter are estimated at -$0.09 with sales reaching $263M over the same period.The EPS is expected to grow by 20.68% this year, but quarterly earnings will post 20.70% year-over-year. Quarterly sales are estimated to grow 14.60% in year-over-year returns.

LifeStance Health Group Inc (LFST) Top Institutional Holders

181 institutions hold shares in LifeStance Health Group Inc (LFST), with institutional investors hold 97.43% of the company’s shares. The shares outstanding are 375.96M, and float is at 85.76M with Short Float at 30.20%. Institutions hold 84.51% of the Float.

The top institutional shareholder in the company is TPG GP A, LLC with over 175.28 million shares valued at $1.6 billion. The investor’s holdings represent 46.37% of the LFST Shares outstanding. As of Jun 29, 2023, the second largest holder is Summit Partners, L.P. with 45.73 million shares valued at $417.56 million to account for 12.10% of the shares outstanding. The other top investors are FMR, LLC which holds 26.42 million shares representing 6.99% and valued at over $241.22 million, while Vanguard Group Inc holds 1.97% of the shares totaling 7.44 million with a market value of $67.93 million.

LifeStance Health Group Inc (LFST) Insider Activity

A total of 7 insider transactions have happened at LifeStance Health Group Inc (LFST) in the last six months, with sales accounting for 7 and purchases happening 0 times. The most recent transaction is an insider sale by Mullins Kevin Michael,the company’sChief Development Officer. SEC filings show that Mullins Kevin Michael sold 113,334 shares of the company’s common stock on Dec 01 at a price of $6.54 per share for a total of $0.74 million. Following the sale, the insider now owns 4.69 million shares.

LifeStance Health Group Inc disclosed in a document filed with the SEC on Nov 07 that Mullins Kevin Michael (Chief Development Officer) sold a total of 32,056 shares of the company’s common stock. The trade occurred on Nov 07 and was made at $6.12 per share for $0.2 million. Following the transaction, the insider now directly holds 4.8 million shares of the LFST stock.

Still, SEC filings show that on Nov 06, Mullins Kevin Michael (Chief Development Officer) disposed off 300 shares at an average price of $6.12 for $1836.0. The insider now directly holds 4,836,006 shares of LifeStance Health Group Inc (LFST).